- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/075 - Adénoviridae
Détention brevets de la classe C07K 14/075
Brevets de cette classe: 346
Historique des publications depuis 10 ans
|
5
|
17
|
24
|
16
|
19
|
23
|
25
|
35
|
21
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20172 |
16 |
| The University of North Carolina at Chapel Hill | 2060 |
14 |
| The Trustees of the University of Pennsylvania | 4368 |
12 |
| University of Massachusetts | 2251 |
12 |
| Glaxosmithkline Biologicals S.A. | 1652 |
11 |
| The Salk Institute for Biological Studies | 445 |
8 |
| Children's Medical Research Institute | 65 |
7 |
| Janssen Vaccines & Prevention B.V. | 311 |
6 |
| University of Washington through its Center for Commercialization | 507 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6500 |
5 |
| University of Florida Research Foundation, Inc. | 4060 |
5 |
| Joint Stock Company "BIOCAD" | 191 |
5 |
| Institut Catala D'oncologia (ico) | 16 |
5 |
| The Broad Institute, Inc. | 1856 |
4 |
| Children's National Medical Center | 273 |
4 |
| Fundacio Institut D'investigacio Biomedica de Bellvitge (idibell) | 73 |
4 |
| GenVec, Inc. | 56 |
4 |
| University of Washington | 2361 |
4 |
| Angiocrine BioScience, Inc. | 37 |
4 |
| Forge Biologics, Inc. | 16 |
4 |
| Autres propriétaires | 206 |